Xiaowei Xu

23PUBLICATIONS

183CO-AUTHORS

Tumour immunologyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (23)

Sort by Publication Date:

|Jun 12, 2026

Effector Vδ1 γδ T cells mediate anti-tumor immunity and are reprogrammed by imatinib in human gastrointestinal stromal tumor.

|Jun 11, 2026

Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells.

|Oct 08, 2025

CD8<sup>+</sup> TILs in necrotic tumors after neoadjuvant immunochemotherapy predict outcomes in non-small-cell lung cancer patients.

Haifeng Lin, Yi Han, Lei Guo

|Jul 02, 2025

Spatial profiling of chromatin accessibility in formalin-fixed paraffin-embedded tissues.

Pengfei Guo, Yufan Chen, Liran Mao

|Apr 15, 2025

Overcoming extracellular vesicle-mediated fratricide improves CAR T cell treatment against solid tumors.

Wenqun Zhong, Zhiyuan Qin, Ziyan Yu

|Jan 15, 2025

Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cells.

Yeye Guo, Huaishan Wang, Shujing Liu

Pageof 4

Frequent Collaborators

Alexander C Huang

Meenhard Herlyn

Wei Guo

Ravi K Amaravadi

Tara C Mitchell

Lynn M Schuchter

Huaishan Wang

Serge Y Fuchs

Carl H June

Yeqing Chen

Frequent Collaborators

Alexander C Huang

Meenhard Herlyn

Wei Guo

Ravi K Amaravadi